Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Injection for relapsing MS with no flu-like effects. | Injectable disease-modifying therapy for relapsing multiple sclerosis. |
| Body system | Brain & Nerves | Brain & Nerves |
| Drug class | Multiple sclerosis therapies | Multiple sclerosis therapies |
| Supply | Prescription only | Prescription only |
| Main uses | Relapsing MS, Clinically isolated syndrome | Relapsing MS, Clinically isolated syndrome |
| How it works | Diverts the immune system away from attacking nerve coverings. | Calms the immune attacks on nerve coverings. |
| Starts working | Months for benefit | Months for benefit |
| Half-life | Not applicable | Hours (effect lasts longer) |
| Typical adult dose | 20 mg daily or 40 mg three times a week by subcutaneous injection. | Depends on the product: 30 micrograms IM weekly, 22–44 micrograms SC three times a week, or 250 micrograms SC every other day. |
| Forms | Subcutaneous injection | Subcutaneous injection, Intramuscular injection |
| Common side effects | Injection site reactions, Flushing, Chest tightness after injection, Anxiety | Flu-like symptoms, Injection site reactions, Headache, Muscle aches |
| Serious side effects | Lipoatrophy at injection sites, Immediate post-injection reaction, Liver injury (rare) | Liver injury, Depression, Low blood counts, Thyroid problems |
| Don't take if | Allergy to glatiramer or mannitol | Severe depression; Uncontrolled epilepsy; Decompensated liver disease |
| Alcohol | Usually no problem in moderation. No known interaction. | Best to limit. Alcohol adds liver stress. |
| Pregnancy | Use with cautionConsidered relatively safe; discuss with your specialist. | Use with cautionStop before planned pregnancy or review risk with specialist. |
| Breastfeeding | Generally considered safeNot absorbed orally by the baby. | Generally considered safeLarge molecule; minimal transfer into milk. |
| In use since | — | — |
| Brand names | United States: Copaxone, GlatopaUnited Kingdom: Copaxone, BrabioIndia: Copaxone | United States: Avonex, Rebif, BetaseronUnited Kingdom: Avonex, Rebif, BetaferonIndia: Avonex, Rebif, Betaferon |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | L03AX13 | L03AB07 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker